Solid Tumor Therapeutics Market Report

China Solid Tumor Therapeutics Industry Market Research Report 2023-2029

  • POSTDATE：Sep 25, 2023
  • PAGES：144
  • REPORT CODE：GMM1813524
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • This report elaborates on the current development of the Solid Tumor Therapeutics industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Novartis

    • Kyowa Hakko Kirin Co, Ltd

    • Hoffmann-La Roche Ltd

    • Baxter International, Inc

    • Biogen Idec, Inc

    • Johnson & Johnson

    • Boehringer Ingelheim GmbH

    • Abbott Laboratories, Inc

    • GlaxoSmithKline plc

    By Type:

    • Immunotherapy

    • Chemotherapy

    • Targeted therapy

    • Hormone therapy

    By Application:

    • Others

    • Cervical Cancer

    • Breast Cancer

    • Colorectal Cancer

    • Lung Cancer

    • Prostate Cancer

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Solid Tumor Therapeutics Market Overview 2018-2029

    • 1.1 China Solid Tumor Therapeutics Industry Development Overview

    • 1.2 China Solid Tumor Therapeutics Industry Development History

    • 1.3 China Solid Tumor Therapeutics Industry Market Size (2018-2029)

    • 1.4 China Solid Tumor Therapeutics Market Analysis by Type from Production Side

      • 1.4.1 China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

      • 1.4.2 China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

      • 1.4.3 China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Targeted therapy (2018-2029)

      • 1.4.4 China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Hormone therapy (2018-2029)

    • 1.5 China Solid Tumor Therapeutics Market Analysis by Application from Consumption End

      • 1.5.1 China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Cervical Cancer (2018-2029)

      • 1.5.3 China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.4 China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

      • 1.5.5 China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

      • 1.5.6 China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

    • 1.6 China Solid Tumor Therapeutics Market Analysis by Region

      • 1.6.1 North China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    Chapter 2 China Solid Tumor Therapeutics Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Solid Tumor Therapeutics Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Solid Tumor Therapeutics Market Status and Competition Analysis in 2023

      • 2.2.3 China Solid Tumor Therapeutics Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Solid Tumor Therapeutics Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Solid Tumor Therapeutics Industry Development

    Chapter 3 Solid Tumor TherapeuticsIndustry Chain Analysis

    • 3.1 Solid Tumor Therapeutics Industry Chain

    • 3.2 Solid Tumor Therapeutics Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Solid Tumor Therapeutics Market

    • 3.3 Solid Tumor Therapeutics Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Solid Tumor Therapeutics Market

    Chapter 4 China Solid Tumor Therapeutics Market, by Type

    • 4.1 China Solid Tumor Therapeutics Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Solid Tumor Therapeutics Total Production Volume and Growth Rate from Production Side

    • 4.5 China Solid Tumor Therapeutics Production Volume and Growth Rate, by Type

      • 4.5.1 China Solid Tumor Therapeutics Production Volume and Growth Rate of Immunotherapy

      • 4.5.2 China Solid Tumor Therapeutics Production Volume and Growth Rate of Chemotherapy

      • 4.5.3 China Solid Tumor Therapeutics Production Volume and Growth Rate of Targeted therapy

      • 4.5.4 China Solid Tumor Therapeutics Production Volume and Growth Rate of Hormone therapy

    Chapter 5 China Solid Tumor Therapeutics Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Solid Tumor Therapeutics Total Market Size and Growth Rate from Consumption End

    • 5.5 China Solid Tumor Therapeutics Market Size and Growth Rate, by Application

      • 5.5.1 China Solid Tumor Therapeutics Market Size and Growth Rate of Others

      • 5.5.2 China Solid Tumor Therapeutics Market Size and Growth Rate of Cervical Cancer

      • 5.5.3 China Solid Tumor Therapeutics Market Size and Growth Rate of Breast Cancer

      • 5.5.4 China Solid Tumor Therapeutics Market Size and Growth Rate of Colorectal Cancer

      • 5.5.5 China Solid Tumor Therapeutics Market Size and Growth Rate of Lung Cancer

      • 5.5.6 China Solid Tumor Therapeutics Market Size and Growth Rate of Prostate Cancer

    Chapter 6 China Solid Tumor Therapeutics Market, by Region

    • 6.1 China Solid Tumor Therapeutics Production Volume and Production Value, by Region

    • 6.2 China Solid Tumor Therapeutics Sales Volume and Sales Value, by Region

    Chapter 7 North China Solid Tumor Therapeutics Market Analysis

    • 7.1 North China Solid Tumor Therapeutics Market, by Type

    • 7.2 North China Solid Tumor Therapeutics Market, by Application

    Chapter 8 Central China Solid Tumor Therapeutics Market Analysis

    • 8.1 Central China Solid Tumor Therapeutics Market, by Type

    • 8.2 Central China Solid Tumor Therapeutics Market, by Application

    Chapter 9 South China Solid Tumor Therapeutics Market Analysis

    • 9.1 South China Solid Tumor Therapeutics Market, by Type

    • 9.2 South China Solid Tumor Therapeutics Market, by Application

    Chapter 10 East China Solid Tumor Therapeutics Market Analysis

    • 10.1 East China Solid Tumor Therapeutics Market, by Type

    • 10.2 East China Solid Tumor Therapeutics Market, by Application

    Chapter 11 Northeast China Solid Tumor Therapeutics Market Analysis

    • 11.1 Northeast China Solid Tumor Therapeutics Market, by Type

    • 11.2 Northeast China Solid Tumor Therapeutics Market, by Application

    Chapter 12 Southwest China Solid Tumor Therapeutics Market Analysis

    • 12.1 Southwest China Solid Tumor Therapeutics Market, by Type

    • 12.2 Southwest China Solid Tumor Therapeutics Market, by Application

    Chapter 13 Northwest China Solid Tumor Therapeutics Market Analysis

    • 13.1 Northwest China Solid Tumor Therapeutics Market, by Type

    • 13.2 Northwest China Solid Tumor Therapeutics Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Novartis

        • 14.1.1 Novartis Company Profile

        • 14.1.2 Novartis Solid Tumor Therapeutics Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 Kyowa Hakko Kirin Co, Ltd

        • 14.2.1 Kyowa Hakko Kirin Co, Ltd Company Profile

        • 14.2.2 Kyowa Hakko Kirin Co, Ltd Solid Tumor Therapeutics Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Hoffmann-La Roche Ltd

        • 14.3.1 Hoffmann-La Roche Ltd Company Profile

        • 14.3.2 Hoffmann-La Roche Ltd Solid Tumor Therapeutics Market Performance

        • 14.3.3 Product&Service Introduction

      • 14.4 Baxter International, Inc

        • 14.4.1 Baxter International, Inc Company Profile

        • 14.4.2 Baxter International, Inc Solid Tumor Therapeutics Market Performance

        • 14.4.3 Product&Service Introduction

      • 14.5 Biogen Idec, Inc

        • 14.5.1 Biogen Idec, Inc Company Profile

        • 14.5.2 Biogen Idec, Inc Solid Tumor Therapeutics Market Performance

        • 14.5.3 Product&Service Introduction

      • 14.6 Johnson & Johnson

        • 14.6.1 Johnson & Johnson Company Profile

        • 14.6.2 Johnson & Johnson Solid Tumor Therapeutics Market Performance

        • 14.6.3 Product&Service Introduction

      • 14.7 Boehringer Ingelheim GmbH

        • 14.7.1 Boehringer Ingelheim GmbH Company Profile

        • 14.7.2 Boehringer Ingelheim GmbH Solid Tumor Therapeutics Market Performance

        • 14.7.3 Product&Service Introduction

      • 14.8 Abbott Laboratories, Inc

        • 14.8.1 Abbott Laboratories, Inc Company Profile

        • 14.8.2 Abbott Laboratories, Inc Solid Tumor Therapeutics Market Performance

        • 14.8.3 Product&Service Introduction

      • 14.9 GlaxoSmithKline plc

        • 14.9.1 GlaxoSmithKline plc Company Profile

        • 14.9.2 GlaxoSmithKline plc Solid Tumor Therapeutics Market Performance

        • 14.9.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Solid Tumor Therapeutics Industry Research Conclusions

    • 15.2 Solid Tumor Therapeutics Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Solid Tumor Therapeutics Industry Market Size (2018-2029)

    • Figure China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Immunotherapy (2018-2029)

    • Figure China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Chemotherapy (2018-2029)

    • Figure China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Targeted therapy (2018-2029)

    • Figure China Solid Tumor Therapeutics Production Volume, Production Value and Growth Rate of Hormone therapy (2018-2029)

    • Figure China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Cervical Cancer (2018-2029)

    • Figure China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Colorectal Cancer (2018-2029)

    • Figure China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Lung Cancer (2018-2029)

    • Figure China Solid Tumor Therapeutics Sales Volume, Sales Value and Growth Rate of Prostate Cancer (2018-2029)

    • Figure North China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Central China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure South China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure East China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Solid Tumor Therapeutics Market Size and Growth Rate from 2018-2029

    • Figure Solid Tumor Therapeutics Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Solid Tumor Therapeutics Market Share by Type in 2018

    • Figure China Solid Tumor Therapeutics Market Share by Type in 2023

    • Figure China Solid Tumor Therapeutics Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Solid Tumor Therapeutics Production Volume and Growth Rate of Immunotherapy (2018-2023)

    • Figure China Solid Tumor Therapeutics Production Volume and Growth Rate of Chemotherapy (2018-2023)

    • Figure China Solid Tumor Therapeutics Production Volume and Growth Rate of Targeted therapy (2018-2023)

    • Figure China Solid Tumor Therapeutics Production Volume and Growth Rate of Hormone therapy (2018-2023)

    • Figure China Solid Tumor Therapeutics Market Share by Application in 2018

    • Figure China Solid Tumor Therapeutics Market Share by Application in 2023

    • Figure China Solid Tumor Therapeutics Total Market Size and Growth Rate from Consumption End

    • Figure China Solid Tumor Therapeutics Market Size and Growth Rate of Others (2018-2023)

    • Figure China Solid Tumor Therapeutics Market Size and Growth Rate of Cervical Cancer (2018-2023)

    • Figure China Solid Tumor Therapeutics Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Solid Tumor Therapeutics Market Size and Growth Rate of Colorectal Cancer (2018-2023)

    • Figure China Solid Tumor Therapeutics Market Size and Growth Rate of Lung Cancer (2018-2023)

    • Figure China Solid Tumor Therapeutics Market Size and Growth Rate of Prostate Cancer (2018-2023)

    • Table China Solid Tumor Therapeutics Production Volume by Region (2018-2023)

    • Table China Solid Tumor Therapeutics Production Volume Share by Region (2018-2023)

    • Figure China Solid Tumor Therapeutics Production Volume Share by Region (2018-2023)

    • Table China Solid Tumor Therapeutics Production Value by Region (2018-2023)

    • Table China Solid Tumor Therapeutics Production Value Share by Region (2018-2023)

    • Figure China Solid Tumor Therapeutics Production Value Share by Region (2018-2023)

    • Table China Solid Tumor Therapeutics Sales Volume by Region (2018-2023)

    • Table China Solid Tumor Therapeutics Sales Volume Share by Region (2018-2023)

    • Figure China Solid Tumor Therapeutics Sales Volume Share by Region (2018-2023)

    • Table China Solid Tumor Therapeutics Sales Value by Region (2018-2023)

    • Table China Solid Tumor Therapeutics Sales Value Share by Region (2018-2023)

    • Figure China Solid Tumor Therapeutics Sales Value Share by Region (2018-2023)

    • Table North China Solid Tumor Therapeutics Production Volume by Type (2018-2023)

    • Table North China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Figure North China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Table North China Solid Tumor Therapeutics Sales Volume by Application (2018-2023)

    • Table North China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure North China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Central China Solid Tumor Therapeutics Production Volume by Type (2018-2023)

    • Table Central China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Central China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Table Central China Solid Tumor Therapeutics Sales Volume by Application (2018-2023)

    • Table Central China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Central China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Table South China Solid Tumor Therapeutics Production Volume by Type (2018-2023)

    • Table South China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Figure South China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Table South China Solid Tumor Therapeutics Sales Volume by Application (2018-2023)

    • Table South China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure South China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Table East China Solid Tumor Therapeutics Production Volume by Type (2018-2023)

    • Table East China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Figure East China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Table East China Solid Tumor Therapeutics Sales Volume by Application (2018-2023)

    • Table East China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure East China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northeast China Solid Tumor Therapeutics Production Volume by Type (2018-2023)

    • Table Northeast China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northeast China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northeast China Solid Tumor Therapeutics Sales Volume by Application (2018-2023)

    • Table Northeast China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Southwest China Solid Tumor Therapeutics Production Volume by Type (2018-2023)

    • Table Southwest China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Southwest China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Table Southwest China Solid Tumor Therapeutics Sales Volume by Application (2018-2023)

    • Table Southwest China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Northwest China Solid Tumor Therapeutics Production Volume by Type (2018-2023)

    • Table Northwest China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Figure Northwest China Solid Tumor Therapeutics Production Volume Share by Type (2018-2023)

    • Table Northwest China Solid Tumor Therapeutics Sales Volume by Application (2018-2023)

    • Table Northwest China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Solid Tumor Therapeutics Sales Volume Share by Application (2018-2023)

    • Table Novartis Company Profile

    • Table Novartis Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Kyowa Hakko Kirin Co, Ltd Company Profile

    • Table Kyowa Hakko Kirin Co, Ltd Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Hoffmann-La Roche Ltd Company Profile

    • Table Hoffmann-La Roche Ltd Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Baxter International, Inc Company Profile

    • Table Baxter International, Inc Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Biogen Idec, Inc Company Profile

    • Table Biogen Idec, Inc Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Johnson & Johnson Company Profile

    • Table Johnson & Johnson Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table Abbott Laboratories, Inc Company Profile

    • Table Abbott Laboratories, Inc Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)

    • Table GlaxoSmithKline plc Company Profile

    • Table GlaxoSmithKline plc Solid Tumor Therapeutics Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US